EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles

Xiao Cheng iD, Brian S Henick iD, Ke Cheng iD

ACS Nano · 05.03.2024 · 18 (9) · 6748-6765

DOI: 10.1021/acsnano.3c06462 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 23.02.2024. Verfasst von Xiao Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States. Hauptthemen laut MEDLINE: Neoplasms, Extracellular Vesicles, Antineoplastic Agents. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 210 Literaturangaben. Gefördert von: NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are natural lipid nanoparticles secreted by most types of cells. In malignant cancer, EVs derived from cancer cells contribute to its progression and metastasis by facilitating tumor growth and invasion, interfering with anticancer immunity, and establishing premetastasis niches in distant organs. In recent years, multiple strategies targeting cancer-derived EVs have been proposed to improve cancer patient outcomes, including inhibiting EV generation, disrupting EVs during trafficking, and blocking EV uptake by recipient cells. Developments in EV engineering also show promising results in harnessing cancer-derived EVs as anticancer agents. Here, we summarize the current understanding of the origin and functions of cancer-derived EVs and review the recent progress in anticancer therapy targeting these EVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsExtracellular VesiclesAntineoplastic AgentsHumansBiological Transport

Stichwörter der Autor:innen

BiomaterialsCancer VaccineCancer metastasisCancer therapyDrug deliveryExtracellular vesiclesImmunotherapyNanomedicine

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Joint Department of Biomedical EngineeringNorth Carolina State University, Raleigh, North Carolina 27606, United States.
  • Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Department of Biomedical Engineering, Columbia University, New York, New York 10027, United States.

ORCID-Profile: Xiao Cheng, Brian S Henick, Ke Cheng

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS

Zitieren

APA

Cheng, X., Henick, B. S., & Cheng, K. (2024). Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles. ACS Nano, 18(9), 6748-6765. https://doi.org/10.1021/acsnano.3c06462

Vancouver

Cheng X, Henick BS, Cheng K. Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles. ACS Nano. 2024;18(9):6748-6765. doi:10.1021/acsnano.3c06462

BibTeX
@article{Cheng2024,
  author = {Cheng, Xiao and Henick, Brian S and Cheng, Ke},
  title = {Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {9},
  pages = {6748--6765},
  doi = {10.1021/acsnano.3c06462}
}
Kostenlos starten →